About: Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published in The Lancet

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1991 (uk) article publié dans la revue scientifique The Lancet (fr) im August 1991 veröffentlichter wissenschaftlicher Artikel (de) scientific article published in The Lancet (en) ശാസ്ത്രപ്രബന്ധം (ml)
publication date	wds:Q57555645-1417D63B-CC11-4955-A9E3-0EB4B4F644AA
publication date	1991-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57555645-1B22004A-B244-4E0E-ADC1-B959861F408D
language of work or name	English
author name string	wds:Q57555645-64A674E2-D239-4290-9D17-87F3B461A159 wds:Q57555645-82B80E63-54C4-46B6-B7CF-2CE5FB027A18 wds:Q57555645-9ADAFCFF-9187-47B0-9868-B60833787AD4 wds:Q57555645-C1CB22EC-401F-4533-BB96-8BF4A40D0581 wds:Q57555645-C4A5CDFE-9144-45B8-839B-268D0055A3EB wds:Q57555645-E9E1993E-7827-4FA8-9060-0EADAC8B3CAC wds:Q57555645-FFDF6EA9-D292-4DE2-B421-77D40EC2B047
author name string	M Ho S L Zeger N M Graham J P Phair R Detels L P Park A J Saah
rdfs:label	Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS (en) Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS (nl)
skos:prefLabel	Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS (en) Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS (nl)
name	Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS (en) Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS (nl)
author	wds:Q57555645-8AC215B8-441B-4995-B30C-90F1B9AB7948
author	Sten Vermund
title	wds:Q57555645-057AD3E8-9346-4501-AE51-9E9F1A7138CB
title	Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study (en)
page(s)	wds:Q57555645-88469FCA-73D8-464A-8F36-310DD2B58044
page(s)	265-269
instance of	wds:Q57555645-0927CEC5-0296-4A11-B31B-EA06502147CA
instance of	scholarly article
main subject	wds:Q57555645-0D948F5E-AAB7-46BA-BFF6-24852052363A wds:Q57555645-1F4B7E98-F9C6-44FC-84F1-246CBADC996B wds:Q57555645-2E71FF4A-9158-411F-BB20-73FF73C21118
main subject	wd:Q198504 pneumonia Pneumocystis carinii
PubMed ID	wds:Q57555645-02B84434-3014-4ED5-A83F-124A5A0D9288
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1677108
PubMed ID	1677108
published in	wds:Q57555645-508D19F7-5406-4FBB-92AF-F281E3D7E7E2
published in	The Lancet
issue	wds:Q57555645-2C3E2DC2-6DEB-4DB7-8FD4-E47368EFA606
volume	wds:Q57555645-E93D1FA3-DD46-4DAC-BD0D-245796BEAEDB
issue	8762
volume	338
DOI	wds:Q57555645-42A33157-F36E-4741-848A-FF92B198416D
DOI	http://dx.doi.org/10.1016/0140-6736(91)90414-K
DOI	10.1016/0140-6736(91)90414-K
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57555645
is cites work of	Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy Effectiveness of highly active antiretroviral therapy among HIV-1 infected women Role of bronchoscopy in AIDS. Factors associated with lack of awareness of HIV infection before diagnosis of AIDS. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival AIDS: the statistical basis for public health When should asymptomatic patients with HIV infection be treated with zidovudine? Universal named testing of pregnant women for HIV. Pre-HIV antibody testing--too much fuss? The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature The impact of HIV infection on medical services in drug abuse treatment programs Cost effectiveness analysis of early zidovudine treatment of HIV infected patients Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus Partner notification for HIV infection in the United Kingdom: a look back on seven years experience in Newcastle upon Tyne. Combination Antiretroviral Therapy Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial 7 The management of HIV disease in pregnancy Danish AIDS patients 1988-1993: a recent decline in Pneumocystis carinii pneumonia as AIDS-defining disease related to the period of known HIV positivity. Diarrhoea associated with Clostridium difficile in AIDS patients receiving rifabutin Laboratory investigation of Pneumocystis carinii pneumonia Primary care of the HIV patient: standard practice and new developments in the era of managed care Concorde trial of immediate versus deferred zidovudine Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy Preventive medicine for HIV-infected patients: an analysis of isoniazid prophylaxis for tuberculin reactors and for anergic patients Correlations Between theIn VitroandIn VivoActivity of Anti-HIV Agents: Implications for Future Drug Deyelopment History, general overview, and protection of health care workers. Progression of HIV-infection: markers or determinants Current status of therapy for human immunodeficiency virus type 1. Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus Interaction of Herpes Viruses with HIV: Can Antiherpes Drugs Prolong Survival Among AIDS Patients?
is cites work of	wds:Q33595411-C26C3E7E-B736-4A6F-886F-EB4D23C753FD wds:Q40790802-0C461115-6971-437E-996C-E53DFE552F75 wds:Q42766859-DA695ABB-4CDF-4CC9-8BC1-4402469D0A95 wds:Q33933446-0A0719CB-3F2B-4193-87E8-5D1F4B1E1781 wds:Q35407246-A6FEA928-A27B-46AB-9089-A9376A1040DF wds:Q33560338-67FDF08A-5765-4860-94D0-5DBADA99F2F0 wds:Q36410953-A73CEEE8-6C7F-47EB-B1A5-6B2D3BE3ED8F wds:Q36335275-B42D8A05-62D9-463F-A56E-9FAFFA0CCF63 wds:Q50557062-3F1B5539-2982-414C-8D52-EFDB2414B42B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software